Chambers S - Search Results

1

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study.

Croca S, Bassett P, Chambers S, Davari M, Alber KF, Leach O, Ioannou Y, Giles I, Isenberg D, Rahman A. Croca S, et al. Among authors: chambers s. Arthritis Res Ther. 2015 Feb 9;17(1):26. doi: 10.1186/s13075-015-0539-z. Arthritis Res Ther. 2015. PMID: 25890187 Free PMC article.

2

Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years.

Chambers SA, Allen E, Rahman A, Isenberg D. Chambers SA, et al. Rheumatology (Oxford). 2009 Jun;48(6):673-5. doi: 10.1093/rheumatology/kep062. Epub 2009 Apr 9. Rheumatology (Oxford). 2009. PMID: 19359343

3

Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica.

Chambers S, Raine R, Rahman A, Hagley K, De Ceulaer K, Isenberg D. Chambers S, et al. Lupus. 2008 Aug;17(8):761-9. doi: 10.1177/0961203308089404. Lupus. 2008. PMID: 18625657

4

Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality.

Goldblatt F, Chambers S, Rahman A, Isenberg DA. Goldblatt F, et al. Among authors: chambers s. Lupus. 2009 Jul;18(8):682-9. doi: 10.1177/0961203308101019. Lupus. 2009. PMID: 19502263

5

Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases.

Chambers SA, Isenberg D. Chambers SA, et al. Lupus. 2005;14(3):210-4. doi: 10.1191/0961203305lu2138oa. Lupus. 2005. PMID: 15807198 Review.

6

Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality.

Chambers SA, Charman SC, Rahman A, Isenberg DA. Chambers SA, et al. Ann Rheum Dis. 2007 Sep;66(9):1173-7. doi: 10.1136/ard.2006.062984. Epub 2007 Jan 9. Ann Rheum Dis. 2007. PMID: 17213253 Free PMC article.

7

Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort.

Chambers SA, Raine R, Rahman A, Isenberg D. Chambers SA, et al. Rheumatology (Oxford). 2009 Mar;48(3):266-71. doi: 10.1093/rheumatology/ken479. Epub 2009 Jan 16. Rheumatology (Oxford). 2009. PMID: 19151034

8

Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature.

Cortes S, Chambers S, Jerónimo A, Isenberg D. Cortes S, et al. Among authors: chambers s. Lupus. 2008 Nov;17(11):977-80. doi: 10.1177/0961203308091539. Lupus. 2008. PMID: 18852220 Review.

9

Treatment adherence and clinical outcome in systemic lupus erythematosus.

Chambers SA, Rahman A, Isenberg DA. Chambers SA, et al. Rheumatology (Oxford). 2007 Jun;46(6):895-8. doi: 10.1093/rheumatology/kem016. Epub 2007 Feb 16. Rheumatology (Oxford). 2007. PMID: 17307754 No abstract available.

10

An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period.

Adler M, Chambers S, Edwards C, Neild G, Isenberg D. Adler M, et al. Among authors: chambers s. Rheumatology (Oxford). 2006 Sep;45(9):1144-7. doi: 10.1093/rheumatology/kel039. Epub 2006 Mar 9. Rheumatology (Oxford). 2006. PMID: 16527882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,434 results

Search Page

Filters